Product Name : Rizatriptan Benzoate
Grade : IP / BP / USP
Therapeutic Category : Antimigraine
CAS No : 145202-66-0
COA : Available
MSDS : Available
Rizatriptan is FDA-approved to treat acute migraine attacks with or without aura. It does not prevent future migraine attacks. Rizatriptan is also used off-label to treat cluster headaches.
25 kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.
Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat
5 years if sealed and store away from direct sun light.
The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:
Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.
Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.
North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .
Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.
OCEANIA: Australia, New Zealand, Fiji, etc.